Oriented towards meeting the country's therapeutic needs.

The Medical Specialties Unit is focused on addressing the therapeutic needs of the main clinical areas in public and private hospitals across the country. Our portfolio includes more than 40 clinical-use medicines, and we continue to actively expand it with new products currently undergoing sanitary registration. We serve critical specialties such as oncology, nephrology, hematology, infectious diseases, and cardiology through innovative products that meet the highest national and international quality standards.

Guaranteed Quality and Traceability

Our products comply with all certifications required by the health authority, including Good Storage Practices (GSP), Good Manufacturing Practices (GMP), Good Distribution and Transportation Practices (GDTP), and Good Pharmacovigilance Practices (GVP). This ensures responsible, safe, and fully traceable management throughout the entire supply chain.

Our Approach

We focus our strategy on ensuring strict compliance with technical and administrative requirements, as well as offering competitive pricing—key factors in successful procurement.
What sets us apart is not only the quality of our portfolio, but also the professional team behind each operation. Our unit stands out for its operational capacity, prompt response to quotes and purchase orders, and a genuine commitment to supply continuity, especially in clinical areas where time is critical.
We offer differentiated, high-quality medications aimed at expanding access to new therapies in the country.

Medical
Specialties Unit

We supply products for key therapies in clinical areas of public and private hospitals across the country

Would you like to learn more about our products?

Please fill out the form below with your information and your company's details. Then, if you wish, leave us a comment and click the 'Submit' button. You are important to us and will be attended to as soon as possible.

×

Before sending your message, please read this.

Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse reactions or any other health problem associated with medicines or vaccines.

Pharmacovigilance seeks to ensure that the benefit-risk balance remains favorable throughout the entire life cycle of a medicine, that is, from the time it is authorized until it is withdrawn from the market or its production is discontinued.

Pharmacovigilance seeks to ensure that the benefit-risk balance remains favorable throughout the entire life cycle of a medicine, that is, from the time it is authorized until it is withdrawn from the market or its production is discontinued.

Pharmacovigilance involves various public health activities of risk analysis and management that contribute to the rational use of medicines.

Buscar contenido